HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-08-07Clinical Trial Update: IMPAACT P1058A: Pharmacokinetic Effects of New Antiretroviral Drugs on Children, Adolescents and Young Adults
This clinical trial update reports on the pharmacokinetic effects of new antiretroviral drugs in children, adolescents, and young adults wit…
-
CLINICAL_TRIALS trial_result · 2015-08-07Clinical Trial Update: Impact of Starting a Dolutegravir-based Regimen on HIV-1 Proviral DNA Reservoir Of Treatment Naïve and Experienced Patients [Phase 4]
Phase 4 trial update evaluating the effect of starting a dolutegravir-based regimen on the HIV-1 proviral DNA reservoir in treatment-naive a…
-
FDA approval · 2015-08-05FDA Approved: TRIUMEQ — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for TRIUMEQ (abacavir sulfate, dolutegravir sodium, lamivudine) submitted by ViiV Healthcare. The ac…
-
FDA approval · 2015-08-05FDA Approved: TIVICAY — Supplemental Application (ViiV Healthcare Company)
FDA approves a supplemental application for Tivicay (dolutegravir) submitted by ViiV Healthcare Company.
-
CLINICAL_TRIALS trial_result · 2015-08-05Clinical Trial Update: Improving Diagnosis of Tuberculosis in HIV Infected Children in Asia (Cambodia, Vietnam)and Africa (Burkina Faso, Cameroon) [NA]
A completed clinical trial focused on improving the diagnosis of tuberculosis in HIV-infected children in Asia and Africa. The study was con…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2015-08-05Clinical Trial Update: Optimizing Antiretroviral Therapy in HIV-Infected Children and Adolescents
The clinical trial evaluating optimizing antiretroviral therapy in HIV-infected children and adolescents has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-08-05Clinical Trial Update: Hepatic Safety of Eviplera® in HIV/Hepatitis C (HCV)-Coinfected Patients Without HCV Treatment in the "The HEPAVIR HEPATIC SAFETY Cohort."
Completed cohort study evaluating the hepatic safety of Eviplera (rilpivirine/emtricitabine/tenofovir disoproxil fumarate) in HIV/HCV coinfe…
-
CLINICAL_TRIALS trial_result · 2015-08-04Clinical Trial Update: Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment. [Phase 2]
Phase II trial evaluating peptide T in HIV-positive individuals with cognitive impairment has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2015-08-04Clinical Trial Update: Outcomes of HIV Infected Individuals After Ten Years on Antiretroviral Treatment
This clinical trial update summarizes outcomes in HIV-infected individuals after ten years of antiretroviral therapy.
-
CLINICAL_TRIALS research · 2015-08-04Clinical Trial Update: Influence of Cytochrome P2B6 on Efavirenz Dose in HIV-infected Thai Patients [Phase 1]
Phase 1 clinical trial examining how CYP2B6 genetic variation affects efavirenz dosing in HIV-infected Thai patients.
-
CLINICAL_TRIALS trial_result · 2015-08-04Clinical Trial Update: Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells [Phase 2]
Phase 2 trial investigating atorvastatin for inflammation, coagulopathy, angiogenesis, and T-cell biomarkers in HIV-1 infection has complete…
-
CLINICAL_TRIALS trial_result · 2015-07-31Clinical Trial Update: Effect of Multiple Dosing With BI 201335 on the Pharmacokinetics of Darunavir Co-administered With Ritonavir in Healthy Male and Female Volunteers [Phase 1]
A Phase 1 study assessing how multiple dosing of BI 201335 influences the pharmacokinetics of darunavir when co-administered with ritonavir …
-
CLINICAL_TRIALS trial_result · 2015-07-31Clinical Trial Update: Status of Chronic Liver Disease in Hepatitis C Virus (HCV) Patients Coinfected With Human Immunodeficiency Virus (HIV) in Andalusia
This entry provides a status update for a clinical trial on chronic liver disease in patients coinfected with hepatitis C virus and HIV in A…
-
FDA approval · 2015-07-30FDA Approved: TIVICAY — Supplemental Application (ViiV Healthcare Company)
FDA approved a supplemental application for Tivicay (dolutegravir) submitted by ViiV Healthcare Company.
-
CLINICAL_TRIALS trial_result · 2015-07-30Clinical Trial Update: Medical Marijuana Use in HIV+ Patients: Probability Survey
A completed clinical study evaluating patterns and factors related to medical marijuana use among HIV-positive individuals using a probabili…
-
CLINICAL_TRIALS trial_result · 2015-07-30Clinical Trial Update: Progesterone Supplementation for HIV-positive Pregnant Women on Anti-Retrovirals [Phase 2]
Phase 2 clinical trial evaluating progesterone supplementation in HIV-positive pregnant women on antiretroviral therapy.
-
CLINICAL_TRIALS research · 2015-07-30Clinical Trial Update: Study to Understand the Natural History of HIV/AIDS in the Era of Effective Therapy (SUN Study)
The SUN Study, sponsored by the Centers for Disease Control and Prevention, is a completed observational study aimed at understanding the na…
-
CLINICAL_TRIALS trial_result · 2015-07-29Clinical Trial Update: Behavioral Science Aspects of Rapid Test Acceptance [NA]
A completed study from California State University, Long Beach examined behavioral factors influencing acceptance of rapid diagnostic tests …
-
CLINICAL_TRIALS trial_result · 2015-07-24Clinical Trial Update: Effectiveness of Structured Ecosystems Therapy for Reducing HIV Risk Behaviors and Improving Treatment Adherence in HIV Infected Men Released From Prison [Phase 2]
This Phase 2 trial evaluated Structured Ecosystems Therapy for reducing HIV risk behaviors and improving treatment adherence in HIV-infected…
-
CLINICAL_TRIALS trial_result · 2015-07-24Clinical Trial Update: Integration of Buprenorphine Into HIV Clinical Settings - Primary Care Model (PCM) [Phase 4]
Phase 4 trial update evaluating the integration of buprenorphine treatment into HIV primary care settings to manage opioid use disorder in p…
-
CLINICAL_TRIALS research · 2015-07-24Clinical Trial Update: Resistance in HIV+ in North and South
Clinical trial update for an HIV drug resistance study (NCT02507921). The current trial status is UNKNOWN.
-
FDA approval · 2015-07-23FDA Approved: EVOTAZ — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental application for Evotaz (atazanavir and cobicistat) submitted by E.R. Squibb & Sons, L.L.C., in connection wi…
-
CLINICAL_TRIALS withdrawal · 2015-07-23Clinical Trial Update: Gamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi Sarcoma [Phase 2]
Phase 2 trial of the gamma secretase inhibitor PF-03084014 for AIDS-related Kaposi sarcoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-07-22Clinical Trial Update: Safety and Immune Response of a Rotavirus Vaccine in HIV-infected and Uninfected Children Born to HIV-infected Mothers [Phase 2]
Phase 2 clinical trial assessing safety and immune response of a rotavirus vaccine in HIV-infected and uninfected children born to HIV-infec…
-
CLINICAL_TRIALS trial_result · 2015-07-21Clinical Trial Update: Isentress Re-examination Study (MK-0518-115)
Clinical trial update noting that the Isentress re-examination study MK-0518-115 has completed. The study concerns HIV infection.